BioCorRx (BICX) Profit After Tax Growth (1y) (2011 - 2026)
BioCorRx (BICX) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 2.06% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 100.19% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 11.95% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 24.71% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 18.19% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 0.55% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 49.84% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 28.98% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 45.69% |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.20% |
| Dec 31, 2025 | 104.41% |
| Jun 30, 2025 | 211.61% |
| Mar 31, 2025 | 32.01% |
| Dec 31, 2024 | -20.88% |
| Sep 30, 2024 | -71.49% |
| Jun 30, 2024 | -33.61% |
| Mar 31, 2024 | -22.45% |
| Dec 31, 2023 | 16.68% |
| Sep 30, 2023 | 8.80% |
| Jun 30, 2023 | 29.92% |
| Mar 31, 2023 | -6.94% |
| Dec 31, 2022 | 3.20% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | -24.10% |
| Mar 31, 2022 | 40.34% |
| Dec 31, 2021 | -32.80% |
| Sep 30, 2021 | -73.62% |
| Jun 30, 2021 | -43.80% |
| Mar 31, 2021 | -46.92% |